4.5 Article

Heat-treated emulsions with cross-linking bovine serum albumin interfacial films and different dextran surfaces: Effect of paclitaxel delivery

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 102, Issue 4, Pages 1307-1317

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1002/jps.23468

Keywords

albumin; biocompatibility; biodegradable polymers; cancer; drug delivery; emulsion; microemulsion; nanotechnology; polysaccharide; stability; surfactants

Funding

  1. Ministry of Science and Technology of China (973 Program) [2009CB930402, 2011CB932503]
  2. innovative team of Ministry of Education of China [IRT0911]
  3. National Natural Science Foundation of China (NSFC) [21274026]
  4. Key Project of the National Twelfth-Five Year Research Program of China [2012ZX09304004]

Ask authors/readers for more resources

In this study, a type of biocompatible and biodegradable oil-in-water emulsion for hydrophobic drug delivery was evaluated in vitro and in vivo. Bovine serum albumin (BSA)dextran conjugates with different dextran molecular weights and different conjugation degrees were used as the emulsifier and stabilizer. Paclitaxel (PTX), a hydrophobic antitumor drug, was effectively loaded inside the oil droplets via high-pressure homogenization. The emulsions were heated at 90 degrees C for 1h to eliminate the anaphylaxis of BSA. By virtue of the cross-linked BSA films at the oilwater interfaces produced by the heat treatment and the hydrophilic dextran surfaces, the emulsions are stable in blood serum, as well as stable against long-term storage. In vitro cytotoxicity study verifies that the unloaded emulsions are biocompatible and the PTX-loaded emulsions have similar antitumor activity as PTX solution. In vivo investigation of murine ascites hepatoma H22-tumor-bearing mice demonstrates that the PTX-loaded emulsion with shorter and denser dextran surface has better tumor inhibition and survivability efficacy than the commercial PTX injection. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:13071317, 2013

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available